Cargando…
Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.
Regional chemotherapy allows further exploitation of the steep dose response curve of most chemotherapeutic agents, while systemic toxicity remains tolerable. We investigated the difference in maximally tolerated dose, pharmacokinetics and antitumour effect comparing administration of melphalan as a...
Autores principales: | Marinelli, A., van Dierendonck, J. H., van Brakel, G. M., Irth, H., Kuppen, P. J., Tjaden, U. R., van de Velde, C. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977872/ https://www.ncbi.nlm.nih.gov/pubmed/1764369 |
Ejemplares similares
-
Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997) -
Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.
por: Marinelli, A., et al.
Publicado: (1991) -
Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008) -
Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver
por: Vahrmeijer, A L, et al.
Publicado: (2000) -
A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.
por: Marinelli, A., et al.
Publicado: (1990)